Stories Tagged: FDA

🤷🤷🤷
FDA Extends Review of Applied Therapeutics' Galactosemia Drug

In a recent development, the U.S. Food and Drug Administration (FDA) has announced an extension... (3 revisions)

🤷🤷🤷
Advancements in Breast Cancer Surgery: Lumicell's Imaging Agent and IceCure's Cryoablation Study

In a recent development, the Medical Imaging Drugs Advisory Committee (MIDAC) of the U.S Food... (3 revisions)

🤷🤷🤷
Study Finds Many Cancer Drugs Granted Accelerated Approval Do Not Demonstrate Clinical Benefits

In a study conducted by the U.S. Food and Drug Administration (FDA), it was found that most... (3 revisions)

🤷🤷🤷
NARA Advocates for the Role of Rendering Industry in Reducing Food Waste and Challenges Exclusion from US Strategy

The North American Renderers Association (NARA) is urging the US Environmental Protection Agency... (4 revisions)

🤷🤷🤷
Concerns over Potency and Addictiveness of Nicotine Alternatives in U.S. Vapes

In a recent article by Emma Rumney on Investing.com, it is reported that nicotine alternatives... (5 revisions)

🤷🤷🤷
Daré Bioscience Reports Q4 2023 Earnings and Updates on Women's Health Product Development

Daré Bioscience, Inc. (NASDAQ:DARE) reported its Q4 2023 earnings, surpassing expectations with... (11 revisions)

🤷🤷🤷
Axsome Initiates Phase 3 Trial for Solriamfetol in Binge Eating Disorder

Amylyx Pharmaceuticals' ALS drug, Relyvrio, has failed in a Phase III trial, showing no efficacy... (12 revisions)

🤷🤷🤷
US FDA Approves Basilea Pharmaceutica's Antibiotic for Treatment of Bacterial Infections

A new antibiotic called ceftobiprole, developed by Basilea Pharmaceutica, has been approved by... (13 revisions)

🤷🤷🤷
FDA Investigates Hospitalizations Linked to Mushroom-Infused Chocolate Bars

A series of hospitalizations have prompted the Food and Drug Administration (FDA) to investigate... (14 revisions)

🤷🤷🤷
US FDA Approves Multiple Therapies, Boosting Health Innovations

The U.S. Food and Drug Administration (FDA) has recently made several significant approvals in... (16 revisions)

🤷🤷🤷
US FDA Staff Recommends COVID-19 Vaccines Target JN.1 and KP.2 Subvariants in 2024-25 Campaign

Novavax, a pharmaceutical company, is awaiting a decision from the US Food and Drug... (20 revisions)

🤷🤷🤷
Scottish Refugee Council Expresses Solidarity with Those Affected by UK's Rwanda Act

The Scottish Refugee Council has expressed solidarity with individuals affected by the 'Safety... (30 revisions)

🤷🤷🤷
US Lawmakers Express Concerns Over FDA's Drug Inspection Program in India and China

The US House Committee on China has requested a briefing from the FBI and the intelligence... (52 revisions)